Get the Stockscreener App
9.65
6.63%
0.60
Anika Therapeutics Inc stock is traded at $9.65, with a volume of 208.31K.
It is up +6.63% in the last 24 hours and down -12.27% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$9.05
Open:
$9.11
24h Volume:
208.31K
Relative Volume:
1.95
Market Cap:
$139.13M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-1.9034
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
+9.29%
1M Performance:
-12.27%
6M Performance:
-44.51%
1Y Performance:
-61.12%
1-Day Range:
$9.06
$9.70
1-Week Range:
$8.2205
$9.70
52-Week Range:
$7.8701
$26.48
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.65 | 125.29M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | B. Riley Securities | Buy |
| Nov-01-24 | Reiterated | Barrington Research | Outperform |
| Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
Anika (ANIK) Upgraded to Buy: Here's What You Should Know - sharewise.com
Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, - GlobeNewswire
Price momentum metrics for Anika Therapeutics Inc. explainedTrade Analysis Report & AI Enhanced Trading Signals - Newser
Can a trend reversal in Anika Therapeutics Inc. lead to recoveryJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Is Anika Therapeutics Inc. forming a bottoming baseJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
What to expect from Anika Therapeutics Inc. in the next 30 daysQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Published on: 2025-08-20 01:50:08 - Newser
Using Python tools to backtest Anika Therapeutics Inc. strategiesJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Has Anika Therapeutics Inc. formed a bullish divergenceInsider Selling & Intraday High Probability Alerts - Newser
How to track smart money flows in Anika Therapeutics Inc.Quarterly Profit Report & Reliable Intraday Trade Alerts - Newser
Does Anika Therapeutics Inc. fit your quant trading modelJuly 2025 Movers & Safe Entry Point Identification - Newser
Combining machine learning predictions for Anika Therapeutics Inc.Weekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Volume spikes in Anika Therapeutics Inc. stock – what they meanQuarterly Portfolio Report & Weekly Setup with ROI Potential - Newser
News impact scoring models applied to Anika Therapeutics Inc.Index Update & Precise Buy Zone Tips - Newser
Why Anika Therapeutics Inc. stock attracts strong analyst attention2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Anika Therapeutics shares rise 1.04% intraday after Medtronic announces board appointments and strategic initiatives. - AInvest
Evaluating Anika Therapeutics Inc. with trendline analysisPrice Action & Advanced Swing Trade Entry Plans - Newser
Anika Therapeutics Inc. stock volume spike explained2025 Buyback Activity & Free Safe Capital Growth Stock Tips - Newser
Sentiment analysis tools applied to Anika Therapeutics Inc.Fed Meeting & Low Drawdown Trading Techniques - Newser
Published on: 2025-08-19 20:15:42 - 선데이타임즈
What candlestick patterns are forming on Anika Therapeutics Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - Newser
Fraud Investigation: Levi & Korsinsky Investigates Anika Therapeutics, Inc. (ANIK) on Behalf of Shareholders - ACCESS Newswire
Anika Therapeutics Inc. stock momentum explainedJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
What’s the recovery path for long term holders of Anika Therapeutics Inc.Market Risk Report & Safe Entry Momentum Stock Tips - Newser
Applying big data sentiment scoring on Anika Therapeutics Inc.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Can Anika Therapeutics Inc. hit a new high this monthEntry Point & Community Trade Idea Sharing Platform - Newser
Lost Money on Anika Therapeutics, Inc. (ANIK)? Contact Levi & Korsinsky About Fraud Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK - GlobeNewswire Inc.
Will Anika Therapeutics Inc. benefit from sector rotationMarket Weekly Review & Accurate Buy Signal Alerts - 선데이타임즈
Potential Securities Fraud: Levi & Korsinsky Investigates Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
Technical analysis overview for Anika Therapeutics Inc. stockJuly 2025 Summary & Technical Pattern Based Buy Signals - Newser
How to manage a losing position in Anika Therapeutics Inc.Weekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Navigating Legal Storms: Investor Protections and Governance in Anika Therapeutics Amid Pomerantz Investigation - AInvest
Can Anika Therapeutics Inc. expand into new marketsGold Moves & Verified Short-Term Plans - thegnnews.com
Pomerantz LLP investigates Anika Therapeutics securities fraud claims. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anika Therapeutics Inc Stock (ANIK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):